Skip to main content
. Author manuscript; available in PMC: 2017 Jul 10.
Published in final edited form as: Cancer Cell. 2016 Jan 21;29(2):229–240. doi: 10.1016/j.ccell.2015.12.012

Figure 2. Diversity and Frequency of Genetic Changes Leading to Deregulation of Signaling Pathways in Ampullary Carcinomas.

Figure 2

Mutation frequencies are expressed as a percentage of cases analyzed in the validation screen: intestinal-type, n = 93; pancreatobiliary-type, n = 66. Frequencies of high-level focal amplifications and deletions are expressed as a percentage of cases analyzed in the discovery screen: intestinal-type, n = 32; pancreatobiliary-type, n = 23. Red denotes activated genes and blue denotes inactivated genes.

See also Figure S3 and Table S9.